Remy Cointreau shares climbed after a notable analyst re-rating, closing up 3.7% at €43.32 following an upgrade from UBS. The broker lifted its recommendation to "neutral" from "sell" and increased its 12-month price objective to €44 from €35, attributing the change to stronger conviction in the company's RC Forward three-year transformation programme.
The RC Forward plan, which underpins UBS's revised view, is positioned as a multi-year turnaround effort focused on several strategic priorities. Management intends to accelerate expansion in emerging markets and global travel retail, drive growth from its premium cognac portfolio and streamline operations to speed decision-making. The group has set a target of roughly €100 million in additional operating profit by 2028-29 compared with the 2025-26 baseline.
The transformation was announced alongside Remy Cointreau's full-year FY26 results. Current operating profit fell to €165.4 million, a figure that nonetheless beat the consensus average of €163 million. On an organic basis, the business contracted by 11.5%, which was slightly better than the consensus average decline of 12.8%.
Management and UBS pointed to several headwinds that have weighed on performance. A stronger euro has damped the competitiveness of the group's cognac and spirits exports. In addition, persistent U.S. tariffs and China's retaliatory levies on cognac imports have continued to act as a drag on the business.
Despite that challenging backdrop, Remy Cointreau reported modest organic sales growth of 0.2% for FY26, with total sales reaching €935.3 million. The company launched the RC Forward programme with an explicit aim to simplify the business and accelerate decision making, steps UBS cited when shifting its stance from its previously most bearish rating to neutral.
The combination of a defined multi-year profit recovery roadmap and the material analyst re-rating provided investors a catalyst to push the stock toward the upper range of recent trading. Intraday price action reached a high of €43.62 as market participants reacted to the UBS note and the RC Forward disclosures.
Market context was also notable: the broader U.S. indices were trading under pressure on the day, with the S&P 500, Dow Jones and NASDAQ all lower. That suggests Remy Cointreau's advance was driven by company-specific developments rather than a general risk-on move across equity markets.
Reporter's note: The share move followed the UBS upgrade and the unveiling of a targeted multi-year plan designed to recover operating profit and improve operational responsiveness. The upgrade and raised price target were the primary drivers of the stock's rise during the session.